An optimized conditional suicide switch using doxycycline-dependent expression of human tBid

Cancer Biology and Therapy

Volumn 4, Issue 5, 2005, Pages 532-536

  Knott, Anja ^a   Drueppel, Lars ^a   Beyer, Thomas ^a   Garke, Kristin ^a   Berens, Christian ^a   Herrmann, Martin ^a   Hillen, Wolfgang ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Apoptosis; Doxycycline; Stringent expression control; tBid

Indexed keywords

DOXYCYCLINE; PROTEIN BID;

APOPTOSIS; CELL DEATH; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CYTOTOXICITY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; PROTEIN EXPRESSION; REVIEW; SAFETY; SUICIDE GENE; SURVIVAL;

EID: 25144502434     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.4.5.1658     Document Type: Review

References (15)

1. Sigler A, Schubert P, Hillen W, Niederweis M. Permeation of tetracyclines through membranes of liposomes and Escherichia coli. Eur J Biochem 2000; 267:527-34.
2. Gossen M, Bonin AL, Bujard H. Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biochem. Sci. 1993; 18:471-475.
3. Knott A, Müller Y, Zunino SJ, Berens C, Hillen W. Conditional cell suicide using dox-dependent caspase-2 expression. J Gene Med 2003; 5:343-54.
4. Knott A, Garke K, Urlinger S, Guthmann J, Müller Y, Thellmann M, Hillen W. Tetracycline-dependent gene regulation: combinations of transregulators yield a variety of expression windows. Biotechniques 2002; 32:796-807.
5. Wang K, Yin XM, Chao DT, Milliman CL, Korsmeyer SJ. BID: a novel BH3 domain-only death agonist. Genes Dev 1996; 10:2859-69.
6. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94:491-501.
7. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94:481-90.
8. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89:5547-51.
9. Santerre RF, Allen NE, Hobbs JN, Jr., Rao RN, Schmidt RJ. Expression of prokaryotic genes for hygromycin B and G418 resistance as dominant-selection markers in mouse L cells. Gene 1984; 30:147-56.
10. Colussi PA, Harvey NL, Shearwin-Whyatt LM, Kumar S. Conversion of procaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain. J Biol Chem 1998; 273:26566-70.
11. Butt AJ, Harvey NL, Parasivam G, Kumar S. Dimerization and autoprocessing of the Nedd2 (caspase-2) precursor requires both the prodomain and the carboxyl-terminal regions. J Biol Chem 1998; 273:6703-8.
12. Hwang JJ, Scuric Z, Anderson WF. Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline- responsive expression system. J Virol 1996; 70:8138-41.
13. Paulus W, Baur I, Boyce FM, Breakefield XO, Reeves SA. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol 1996; 70:62-7.
14. Watsuji T, Okamoto Y, Emi N, Katsuoka Y, Hagiwara M. Controlled gene expression with a reverse tetracycline-regulated retroviral vector (RTRV) system. Biochem Biophys Res Commun 1997; 234:769-73.
15. Dugray A, Geay JF, Foudi A, Bonnet ML, Vainchenker W, Wendling F, Louache F, Turhan AG. Rapid generation of a tetracycline-inducible BCR-ABL defective retrovirus using a single autoregulatory retroviral cassette. Leukemia 2001; 15:1658-62.